NCT02349139
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer No drug interventions treatment 1 terminated NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors No drug interventions treatment 1 terminated NCT04381832
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT05191017
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC No drug interventions treatment 1 / 2 withdrawn NCT03551782
A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer treatment 1 completed NCT05169684
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer No drug interventions treatment 2 completed NCT04717154
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer treatment 2 active_not_recruiting NCT03389451
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer diagnostic 2 / 3 completed NCT03822845
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer diagnostic 2 / 3 active_not_recruiting NCT04597411
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer No drug interventions treatment 1 recruiting NCT02803437
Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases Not Available Not Available active_not_recruiting NCT03173859
Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients treatment 2 withdrawn NCT04962919
Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions. No drug interventions Not Available Not Available active_not_recruiting NCT06353386
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) treatment 1 / 2 recruiting NCT02625857
Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer No drug interventions treatment 1 completed NCT02057666
Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer treatment 3 terminated NCT03325127
Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study Not Available Not Available withdrawn NCT03927391
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects treatment 4 completed NCT05393791
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC treatment 2 recruiting NCT02899104
Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer ) No drug interventions Not Available Not Available completed NCT02204072
BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC) No drug interventions treatment 1 completed NCT03016312
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen No drug interventions treatment 3 completed NCT03563014
A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223 No drug interventions Not Available Not Available completed NCT05520138
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) Not Available Not Available completed NCT05743621
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 recruiting NCT05902247
Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy No drug interventions treatment 1 recruiting NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) No drug interventions treatment 1 active_not_recruiting NCT02906605
A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer No drug interventions treatment 2 withdrawn NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT06190899
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 / 2 recruiting NCT05968599
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02162836
A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 completed NCT02592317
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer No drug interventions treatment 1 recruiting NCT03017417
A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer No drug interventions health_services_research Not Available completed NCT04104776
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 recruiting NCT04868604
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) No drug interventions treatment 1 / 2 recruiting NCT04854369
68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly) No drug interventions Not Available Not Available no_longer_available NCT03388346
68Ga PSMA in Preprostatectomy Patients No drug interventions diagnostic 2 / 3 completed NCT02450812
Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany No drug interventions Not Available Not Available completed NCT03431350
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT05156450
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 2 unknown_status